When Russell Snell and his colleagues at the University of Auckland, New Zealand, were recently designing a study to test a candidate Alzheimer's gene, they ran up against a roadblock: How to put together a control group? "It's a problem," says Snell. "How do you identify a person who is not going to develop Alzheimer's?"












